Share
Market Research Report

NORTH AMERICA AND EUROPE ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Drug TypeOral & Parenteral Antibiotics (Vancomycin, Linezolid, Clindamycin, Ceftaroline, Daptomycin, Dalbavancin, Tedizolid, Others) · Topical Antibiotics (Hydrogen Peroxide, Fusidic Acid, Mupirocin, Retapamulin, and Povidone-Iodine)
  • By Infection TypeHospital Acquired ABSSSI · Community Acquired ABSSSI
  • By Route of AdministrationOral · Parenteral · and Topical
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Europe
  • Published In28 Apr 2026
  • Report CodeCMI4273
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Segmentation

  • By Drug Type

    • Oral & Parenteral Antibiotics
      • Vancomycin
      • Linezolid
      • Clindamycin
      • Ceftaroline
      • Daptomycin
      • Dalbavancin
      • Tedizolid
      • Others
    • Topical Antibiotics
      • Hydrogen Peroxide
      • Fusidic Acid
      • Mupirocin
      • Retapamulin
      • Povidone-Iodine
  • By Infection Type

    • Hospital Acquired ABSSSI
    • Community Acquired ABSSSI
  • By Route of Administration

    • Oral
    • Parenteral
    • Topical
  • By Distribution Channel

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Region

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe